2003 Annual Meeting of the Arbeitsgemeinschaft für Angewandte Humanpharmakologie (Association for Applied Human Pharmacology), Bonn, Germany, 23-25 February 2003

http://www.agah-web.de

Oral presentation  [1-10]  [11-20]  [21-24]  

1.	Oral presentation QTc "Time-series data" Robert Hermann, Wilhelm Haverkamp, Ulrike Bischoff BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op001 [Abstract]
2.	Oral presentation Medical Writing Report Writing Kerstin Breithaupt-Grgler, Betsy Hughes-Formella BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op002 [Abstract]
3.	Oral presentation EU-Directive 2001/20/EC Implementation of GCP in the conduct of clinical trials Ingrid Klingmann BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op003 [Abstract]
4.	Oral presentation Preclinical requirements to studies in children Klaus Olejniczak BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op004 [Abstract]
5.	Oral presentation Characteristics of pharmacokinetics and pharmacodynamics in children Ulrike Ebert BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op005 [Abstract]
6.	Oral presentation Clinical drug development for children with asthma Wolfgang Timmer BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op006 [Abstract]
7.	Oral presentation Clinical drug development for children with diabetes or sepsis Heike Jung BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op007 [Abstract]
8.	Oral presentation Declaration of Helsinki Thomas Sudhop BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op008 [Abstract]
9.	Oral presentation Risk-benefit evaluation in approval of traditional and innovative drugs Rashmi Shah BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op009 [Abstract]
10.	Oral presentation Guidelines for drug approval today and tomorrow Maria Holz-Slomczyk BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op010 [Abstract]